Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan flag Japan · Delayed Price · Currency is JPY
2,070.00
-51.00 (-2.40%)
Aug 25, 2026, 3:30 PM JST

Zeria Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
11,20012,6189,5087,2725,721
Depreciation & Amortization
7,3467,5547,5556,1485,399
Loss (Gain) From Sale of Investments
-168208-499-19-14
Loss (Gain) on Equity Investments
180276---
Other Operating Activities
-2,735-1,039-906-530-864
Change in Accounts Receivable
-1,896-4,800-2,075-171-2,029
Change in Inventory
-3,423-1,647-863-150-542
Change in Accounts Payable
5205671,052-207284
Change in Other Net Operating Assets
-1,069-815-1,589814995
Operating Cash Flow
9,95512,92212,18313,1578,950
Operating Cash Flow Growth
-22.96%6.07%-7.40%47.01%29.82%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-2,361-1,429-2,900-2,400-1,064
Cash Acquisitions
---623--
Sale (Purchase) of Intangibles
-534-1,304-998-257-356
Investment in Securities
1741,66247358-1,477
Other Investing Activities
202196255
Investing Cash Flow
-2,701-1,050-3,952-2,574-2,892

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
7--279-
Long-Term Debt Issued
1,1503,27350050016,158
Total Debt Issued
1,1573,27350077916,158
Short-Term Debt Repaid
--143-560--13,241
Long-Term Debt Repaid
-4,533-8,515-5,778-5,628-3,388
Total Debt Repaid
-4,533-8,658-6,338-5,628-16,629
Net Debt Issued (Repaid)
-3,376-5,385-5,838-4,849-471
Repurchase of Common Stock
----673-2,603
Common Dividends Paid
-2,110-1,976-1,935-1,590-1,538
Other Financing Activities
-447-395-351-303-229
Financing Cash Flow
-5,933-7,756-8,124-7,415-4,841

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
2,8467492,4021,346564
Miscellaneous Cash Flow Adjustments
--21-128
Net Cash Flow
4,1674,8632,5104,5141,909

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
7,59411,4939,28310,7577,886
Free Cash Flow Growth
-33.92%23.81%-13.70%36.41%28.02%
Free Cash Flow Margin
8.52%13.16%12.26%15.73%13.25%
Free Cash Flow Per Share
172.28260.73210.59243.52174.71
Levered Free Cash Flow
4,6467,6277,8508,8076,071
Unlevered Free Cash Flow
4,9597,9108,1369,0176,268

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
498492446300304
Cash Income Tax Paid
2,7371,001915564874
Change in Working Capital
-5,868-6,695-3,475286-1,292